Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nibash Budhathoki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Oncologica (Stockholm, Sweden)|June 16, 2015
Second primary malignancy in Burkitt's lymphomaBinay Kumar Shah, Nibash Budhathoki
Anticancer Research|July 1, 2015
Second Primary Malignancy in Anal Carcinoma--A US Population-based StudyBinay Kumar Shah, Nibash Budhathoki
BMJ Case Reports|January 7, 2021
Bone marrow necrosis and fat embolism syndrome: a near fatal complication in previously undiagnosed sickle beta + thalassaemiaNibash Budhathoki, Sunita Timilsina, Bebu Ram, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Targeted therapy for leptomeningeal metastases in non-small cell lung cancer - Changing treatment paradigmsBinay Kumar Shah, Isaac Pak, Nibash Budhathoki, et al.
Anticancer Research|April 5, 2017
Second Primary Malignancy in Bladder Carcinoma - A Population-based StudyAmit Khanal, Nibash Budhathoki, Vijay Pal Singh, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2021
Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue Lymphomas: A SEER Database InterrogationSunita Timilsina, Aaron Damato, Nibash Budhathoki, et al.
SAGE Open Medical Case Reports|June 17, 2017
Pseudo-thrombotic thrombocytopenic purpura presenting as multi-organ dysfunction syndrome: A rare complication of pernicious anemiaSaroj Kandel, Nibash Budhathoki, Shanta Pandey, et al.
European Journal of Gastroenterology & Hepatology|March 28, 2017
Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis CJagannath M Sherigar, Vijay Gayam, Arifa Khan, et al.
The Oncologist|May 31, 2022
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 PandemicDouglas K Marks, Nibash Budhathoki, John Kucharczyk, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Oncologica (Stockholm, Sweden)|June 16, 2015
Second primary malignancy in Burkitt's lymphomaBinay Kumar Shah, Nibash Budhathoki
Anticancer Research|July 1, 2015
Second Primary Malignancy in Anal Carcinoma--A US Population-based StudyBinay Kumar Shah, Nibash Budhathoki
BMJ Case Reports|January 7, 2021
Bone marrow necrosis and fat embolism syndrome: a near fatal complication in previously undiagnosed sickle beta + thalassaemiaNibash Budhathoki, Sunita Timilsina, Bebu Ram, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Targeted therapy for leptomeningeal metastases in non-small cell lung cancer - Changing treatment paradigmsBinay Kumar Shah, Isaac Pak, Nibash Budhathoki, et al.
Anticancer Research|April 5, 2017
Second Primary Malignancy in Bladder Carcinoma - A Population-based StudyAmit Khanal, Nibash Budhathoki, Vijay Pal Singh, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2021
Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue Lymphomas: A SEER Database InterrogationSunita Timilsina, Aaron Damato, Nibash Budhathoki, et al.
SAGE Open Medical Case Reports|June 17, 2017
Pseudo-thrombotic thrombocytopenic purpura presenting as multi-organ dysfunction syndrome: A rare complication of pernicious anemiaSaroj Kandel, Nibash Budhathoki, Shanta Pandey, et al.
European Journal of Gastroenterology & Hepatology|March 28, 2017
Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis CJagannath M Sherigar, Vijay Gayam, Arifa Khan, et al.
The Oncologist|May 31, 2022
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 PandemicDouglas K Marks, Nibash Budhathoki, John Kucharczyk, et al.
Pageof 1